Chemoinformaics analysis of Methyl 2-ethylhexadecanoate
| Molecular Weight | 298.511 | nRot | 15 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 1 |
| Exact Molecular Weight | 298.287 | nRing | 0 |
| Solubility: LogS | -6.882 | nHRing | 0 |
| Solubility: LogP | 7.85 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 58.6721 |
| nHD | 0 | BPOL | 40.7259 |
| QED | 0.263 |
| Synth | 2.429 |
| Natural Product Likeliness | 0.264 |
| NR-PPAR-gamma | 0.028 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.014 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.766 |
| MDCK | 0.0000134 |
| BBB | 0.216 |
| PPB | 0.971723 |
| VDSS | 1.724 |
| FU | 0.0150546 |
| CYP1A2-inh | 0.391 |
| CYP1A2-sub | 0.373 |
| CYP2c19-inh | 0.432 |
| CYP2c19-sub | 0.271 |
| CYP2c9-inh | 0.221 |
| CYP2c9-sub | 0.925 |
| CYP2d6-inh | 0.252 |
| CYP2d6-sub | 0.078 |
| CYP3a4-inh | 0.476 |
| CYP3a4-sub | 0.109 |
| CL | 4.799 |
| T12 | 0.093 |
| hERG | 0.306 |
| Ames | 0.007 |
| ROA | 0.024 |
| SkinSen | 0.952 |
| Carcinogencity | 0.051 |
| EI | 0.954 |
| Respiratory | 0.932 |
| NR-Aromatase | 0.072 |
| Antiviral | Yes |
| Prediction | 0.619194 |